BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25355997)

  • 1. In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus.
    Carvalho OV; Saraiva GL; Ferreira CG; Felix DM; Fietto JL; Bressan GC; Almeida MR; Silva Júnior A
    Can J Vet Res; 2014 Oct; 78(4):283-9. PubMed ID: 25355997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antiviral efficacy of caffeic acid against canine distemper virus.
    Wu ZM; Yu ZJ; Cui ZQ; Peng LY; Li HR; Zhang CL; Shen HQ; Yi PF; Fu BD
    Microb Pathog; 2017 Sep; 110():240-244. PubMed ID: 28687324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro.
    Lanave G; Cavalli A; Martella V; Fontana T; Losappio R; Tempesta M; Decaro N; Buonavoglia D; Camero M
    J Virol Methods; 2017 Oct; 248():207-211. PubMed ID: 28760649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of ribavirin against canine distemper virus.
    Elia G; Belloli C; Cirone F; Lucente MS; Caruso M; Martella V; Decaro N; Buonavoglia C; Ormas P
    Antiviral Res; 2008 Feb; 77(2):108-13. PubMed ID: 17949825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of viral RNA synthesis in canine distemper virus infection by proanthocyanidin A2.
    Gallina L; Dal Pozzo F; Galligioni V; Bombardelli E; Scagliarini A
    Antiviral Res; 2011 Dec; 92(3):447-52. PubMed ID: 22020306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of canine distemper virus by flavonoids and phenolic acids: implications of structural differences for antiviral design.
    Carvalho OV; Botelho CV; Ferreira CG; Ferreira HC; Santos MR; Diaz MA; Oliveira TT; Soares-Martins JA; Almeida MR; Silva A
    Res Vet Sci; 2013 Oct; 95(2):717-24. PubMed ID: 23664014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
    Di Bisceglie AM; Janczweska-Kazek E; Habersetzer F; Mazur W; Stanciu C; Carreno V; Tanasescu C; Flisiak R; Romero-Gomez M; Fich A; Bataille V; Toh ML; Hennequi M; Zerr P; Honnet G; Inchauspé G; Agathon D; Limacher JM; Wedemeyer H
    Gastroenterology; 2014 Jul; 147(1):119-131.e3. PubMed ID: 24657484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-canine distemper virus activities of ex vivo-expanded canine natural killer cells.
    Park JY; Shin DJ; Lee SH; Lee JJ; Suh GH; Cho D; Kim SK
    Vet Microbiol; 2015 Apr; 176(3-4):239-49. PubMed ID: 25680810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral efficacy of favipiravir against canine distemper virus infection in vitro.
    Xue X; Zhu Y; Yan L; Wong G; Sun P; Zheng X; Xia X
    BMC Vet Res; 2019 Sep; 15(1):316. PubMed ID: 31477101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
    Gallegos KM; Drusano GL; D Argenio DZ; Brown AN
    J Infect Dis; 2016 Oct; 214(8):1192-7. PubMed ID: 27496974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-methylmercaptopurine riboside, a thiopurine nucleoside with antiviral activity against canine distemper virus in vitro.
    de Carvalho OV; Félix DM; de Camargo Tozato C; Fietto JLR; de Almeida MR; Bressan GC; Pena LJ; Silva-Júnior A
    Virol J; 2017 Jun; 14(1):124. PubMed ID: 28651549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and application of a Vero cell line stably expressing raccoon dog SLAM, the cellular receptor of canine distemper virus].
    Zhao J; Yan R; Zhang H; Zhang L; Hu B; Bai X; Shao X; Chai X; Yan X; Wu W
    Wei Sheng Wu Xue Bao; 2012 Dec; 52(12):1515-23. PubMed ID: 23457801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
    Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
    Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective primary isolation of wild-type canine distemper virus in MDCK, MV1 Lu and Vero cells without nucleotide sequence changes within the entire haemagglutinin protein gene and in subgenomic sections of the fusion and phospho protein genes.
    Lednicky JA; Meehan TP; Kinsel MJ; Dubach J; Hungerford LL; Sarich NA; Witecki KE; Braid MD; Pedrak C; Houde CM
    J Virol Methods; 2004 Jun; 118(2):147-57. PubMed ID: 15081610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Screen against Canine Distemper Virus-Induced Membrane Fusion Activity.
    Shrestha N; Gall FM; Vesin J; Chambon M; Turcatti G; Fotiadis D; Riedl R; Plattet P
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.
    Sadeghi F; Bokharaei-Salim F; Salehi-Vaziri M; Monavari SH; Alavian SM; Salimi S; Vahabpour R; Keyvani H
    J Med Virol; 2014 Sep; 86(9):1499-506. PubMed ID: 24889558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
    Andronova VL; Jasko MV; Kukhanova MK; Skoblov YS; Deryabin PG; Galegov GA
    Vopr Virusol; 2014; 59(6):32-5. PubMed ID: 25929034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha inhibits the emergence of cellular stress response-dependent morbillivirus large plaque variants.
    Heller M; Vasconcelos D; Cummins J; Oglesbee M
    Antiviral Res; 1998 Jun; 38(3):195-207. PubMed ID: 9754888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.